“…Prolyl–π interactions have been proposed to be critical to the binding of polyproline helices, which are binding epitopes in a number of different protein–protein interactions, including recognition events with SH3 domains, WW domains, EVH1 domains, GYF domains, EUV domains, and the single‐domain profilin proteins 5. 6 These protein–protein interactions are involved in a wide range of signaling pathways,6, 7 and some are associated with disease states, including HIV infection, Alzheimer’s, and cancer,8–11 making them potential therapeutic targets 12–15. The recognition domains for polyproline helices contain an aromatic cleft in which at least one proline binds 5.…”